Skip to main content

Cancer Progress and Priorities: Gastric Cancer.

Publication ,  Journal Article
Alagesan, P; Goodwin, JC; Garman, KS; Epplein, M
Published in: Cancer Epidemiol Biomarkers Prev
April 3, 2023

Gastric cancer, the fifth leading cause of cancer worldwide, is estimated to be responsible for approximately 1.4% of all new cancers and 1.8% of all cancer-related deaths in the United States. Despite declining incidence rates and improved survival rates, however, gastric cancer continues to disproportionately affect racial and ethnic minorities and individuals of lower socioeconomic status at higher rates than the general population. To improve outcomes globally and address disparities within the United States, continued improvements are needed in risk factor modification and biomarker development and to improve access to existing preventative measures such as genetic testing and H. pylori eradication testing, in addition to expanding upon current clinical guidelines for premalignant disease to address gaps in endoscopic surveillance and early detection.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

April 3, 2023

Volume

32

Issue

4

Start / End Page

473 / 486

Location

United States

Related Subject Headings

  • United States
  • Stomach Neoplasms
  • Risk Factors
  • Racial Groups
  • Precancerous Conditions
  • Incidence
  • Humans
  • Helicobacter Infections
  • Epidemiology
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alagesan, P., Goodwin, J. C., Garman, K. S., & Epplein, M. (2023). Cancer Progress and Priorities: Gastric Cancer. Cancer Epidemiol Biomarkers Prev, 32(4), 473–486. https://doi.org/10.1158/1055-9965.EPI-22-0994
Alagesan, Priya, Jessica C. Goodwin, Katherine S. Garman, and Meira Epplein. “Cancer Progress and Priorities: Gastric Cancer.Cancer Epidemiol Biomarkers Prev 32, no. 4 (April 3, 2023): 473–86. https://doi.org/10.1158/1055-9965.EPI-22-0994.
Alagesan P, Goodwin JC, Garman KS, Epplein M. Cancer Progress and Priorities: Gastric Cancer. Cancer Epidemiol Biomarkers Prev. 2023 Apr 3;32(4):473–86.
Alagesan, Priya, et al. “Cancer Progress and Priorities: Gastric Cancer.Cancer Epidemiol Biomarkers Prev, vol. 32, no. 4, Apr. 2023, pp. 473–86. Pubmed, doi:10.1158/1055-9965.EPI-22-0994.
Alagesan P, Goodwin JC, Garman KS, Epplein M. Cancer Progress and Priorities: Gastric Cancer. Cancer Epidemiol Biomarkers Prev. 2023 Apr 3;32(4):473–486.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

April 3, 2023

Volume

32

Issue

4

Start / End Page

473 / 486

Location

United States

Related Subject Headings

  • United States
  • Stomach Neoplasms
  • Risk Factors
  • Racial Groups
  • Precancerous Conditions
  • Incidence
  • Humans
  • Helicobacter Infections
  • Epidemiology
  • 42 Health sciences